Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Radiotherapy 9 Drug Therapy 9 Cisplatin 9 Gemcitabine 8 Docetaxel 7 Carboplatin 7 Blood Specimen Collection 7 Nivolumab 6 Fluorouracil 6 Pemetrexed 5 Capecitabine 5 pembrolizumab 4 Surveys and Questionnaires 4 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oxaliplatin 4 Exercise 4 Everolimus 4 Data Collection 4 Cetuximab 4 indibulin 3 icotinib 3 Vincristine 3 Trastuzumab 3 Standard of Care 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Interleukin-2 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Immunomodulating Agents × Tumor-Agnostic × Clear all

NCT04696250 2021-01-06

AVATAR

University Hospital, Caen

5,000,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡